Adial Pharmaceuticals competitorsClear all

Adial Pharmaceuticals's top competitors include Biogen, Inovio Pharmaceuticals, MyoKardia and Athersys.
Adial Pharmaceuticals
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders in the United States.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Founding Date
Founding Date
2010
Founding Date
1978
Founding Date
1979
Founding Date
2012
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Charlottesville, US HQ
Charlottesville, US
Charlottesville, US
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
Blue Bell, US HQ
San Diego, US
San Diego, US
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Employees
Employees
3
Employees
7,8007% increase
Employees
2811% increase
Employees
1024% increase
Employees
7514% increase
Valuation ($)
Valuation ($)
20.8 m
Valuation ($)
44.3 b
Valuation ($)
244.1 m
Valuation ($)
2.2 b
Valuation ($)
241.1 m
Twitter followers
Twitter followers
66
Twitter followers
27 k
Twitter followers
1.9 k
Twitter followers
634
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
38
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.3
Average likes per tweet (last 30 days)
15.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6
Average likes per tweet (last 30 days)
13.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
66.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
332951
Alexa Website Rank
83540
Alexa Website Rank
1151286
Alexa Website Rank
337057
Alexa Website Rank
609659

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$30.5m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$24.3m (FY, 2018)
Net income
Net income
N/A
Net income
$3.7b (FY, 2016)
Net income
($97m) (FY, 2018)
Net income
($67.7m) (FY, 2018)
Net income
N/A

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
620 (FY, 2016)
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 63.3m
Total funding raised
$ 98m
Total funding raised
$ 9m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Inovio Pharmaceuticals
HQ
Blue Bell, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
75↑ 14% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company